Literature DB >> 3301550

Cytotoxic effects of daunomycin on retinal pigment epithelium in vitro.

M Weller, K Heimann, P Wiedemann.   

Abstract

Proliferative vitreoretinopathy (PVR), the most severe complication of retinal detachment surgery and posterior segment ocular trauma, is characterized by the intraocular proliferation of non-neoplastic cells with formation of vitreal and periretinal membranes resulting in renewed traction retinal detachment. As retinal pigment epithelial (RPE) cells have been shown to play an essential role in the development of PVR, we investigated the acute and chronic effects of daunomycin on the morphology and viability of porcine RPE cells in vitro. The intense and complete inhibition of cell proliferation reported in this study adds to previous evidence that daunomycin may be useful for pharmacological treatment of human PVR.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301550     DOI: 10.1007/BF02175455

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  9 in total

1.  Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation).

Authors:  R Machemer; H Laqua
Journal:  Am J Ophthalmol       Date:  1975-07       Impact factor: 5.258

2.  Epiretinal and vitreous membranes. Comparative study of 56 cases.

Authors:  A Kampik; K R Kenyon; R G Michels; W R Green; Z C de la Cruz
Journal:  Arch Ophthalmol       Date:  1981-08

Review 3.  Proliferative vitreoretinopathy and chemotherapeutic agents.

Authors:  G A Peyman; J Schulman
Journal:  Surv Ophthalmol       Date:  1985 May-Jun       Impact factor: 6.048

4.  [Proliferative vitreoretinopathy. Pathogenesis and possibilities for treatment with cytostatic drugs].

Authors:  P Wiedemann; K Heimann
Journal:  Klin Monbl Augenheilkd       Date:  1986-06       Impact factor: 0.700

5.  Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit.

Authors:  M Santana; P Wiedemann; M Kirmani; D S Minckler; R Patterson; N Sorgente; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

6.  Growth characteristics and ultrastructure of human retinal pigment epithelium in vitro.

Authors:  M T Flood; P Gouras; H Kjeldbye
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-11       Impact factor: 4.799

7.  A Fickian diffusion transport process with features of transport catalysis. Doxorubicin transport in human red blood cells.

Authors:  M Dalmark; H H Storm
Journal:  J Gen Physiol       Date:  1981-10       Impact factor: 4.086

8.  Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo.

Authors:  P Wiedemann; N Sorgente; C Bekhor; R Patterson; T Tran; S J Ryan
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

9.  Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy.

Authors:  M Kirmani; M Santana; N Sorgente; P Wiedemann; S J Ryan
Journal:  Retina       Date:  1983 Fall-Winter       Impact factor: 4.256

  9 in total
  8 in total

1.  Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro.

Authors:  J Cai; R Wei; X Ma; H Zhu; Y Li
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Evaluation of daunomycin toxicity on lens epithelium in vitro.

Authors:  M Weller; P Wiedemann; R Fischbach; C Hartmann; K Heimann
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

Review 3.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

4.  Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.

Authors:  J A Khawly; P Saloupis; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

5.  Growth inhibition of human Tenon's capsule fibroblasts and rabbit dermal fibroblasts with non-carcinogenic N-alkylated anthracyclines.

Authors:  U H Steinhorst; E P Chen; S F Freedman; R Machemer; D L Hatchell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-06       Impact factor: 3.117

6.  [Possible role of alkylphosphocholines in retinal reattachment surgery].

Authors:  K H Eibl; G P Lewis; K Betts; K A Linberg; A Gandorfer; S K Fisher; A Kampik
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

7.  Demonstration of mononuclear phagocytes in a human epiretinal membrane using a monoclonal anti-human macrophage antibody.

Authors:  M Weller; K Heimann; P Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

Review 8.  Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid.

Authors:  Francesco Morescalchi; Sarah Duse; Elena Gambicorti; Mario R Romano; Ciro Costagliola; Francesco Semeraro
Journal:  Mediators Inflamm       Date:  2013-09-30       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.